Key result
Dedicated transcatheter aortic valves with leaflet-clipping mechanisms outperform off-label non-dedicated valves in patients with pure native aortic regurgitation at high operative risk.
Why the study?
Do dedicated transcatheter aortic valve platforms with leaflet-clipping mechanisms improve clinical and valve performance outcomes compared to off-label non-dedicated valves in patients with pure native aortic regurgitation?
Do dedicated transcatheter aortic valve platforms with leaflet-clipping mechanisms improve clinical and valve performance outcomes compared to off-label non-dedicated valves in patients with pure native aortic regurgitation?
Answers are grounded in this paper and cite their sources.
This editorial advocates against the off-label use of non-dedicated transcatheter valves for pure native aortic regurgitation and calls for stronger guideline recommendations supporting dedicated leaflet-clipping TAVI platforms.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Nicolas M. Van Mieghem (2026) conducted an editorial in Pure native aortic regurgitation. Dedicated transcatheter aortic valve implantation (TAVI) platforms with leaflet-clipping mechanisms vs. Off-label non-dedicated transcatheter aortic valves was evaluated. Dedicated transcatheter aortic valves with leaflet-clipping mechanisms outperform off-label non-dedicated valves in patients with pure native aortic regurgitation at high operative risk.
Synapse has enriched 10 related papers. Consider them for comparative context: